Indian Journal of Radiology Indian Journal of Radiology  

   Login   | Users online: 1852

Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size     

This article has been cited by
1Contrast Enhanced Computed Tomography Characterization of Fluorodeoxygluocose-Avid Regional and Non-Regional Lymph Nodes in Patients with Suspicion of Metastatic Bladder Cancer
Muhammad A. Chaudhry,Richard Wahl,Lujaien Al-Rubaiey Kadhim,Atif Zaheer
Journal of Clinical Imaging Science.2013;3()66
[DOI]
2Nuclear medicine in urological cancers: what is new?
Cristina Nanni,Lucia Zanoni,Stefano Fanti
Future Oncology.2014;10(13)2061
[DOI]
3Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers
Jorge D. Oldan,Shetal N. Shah,Tracy Lynn Rose
Magnetic Resonance Imaging Clinics of North America.2017;25(2)335
[DOI]
4Proposal of a New Acquisition Protocol for Bladder Cancer Visualization With 18F-FDG PET/CT
Sotirios Chondrogiannis,Maria Cristina Marzola,Patrick M. Colletti,Domenico Rubello
Clinical Nuclear Medicine.2015;40(1)e78
[DOI]
5Suppression of 18F-FDG signal in the bladder on small animal PET-CT
Lorena Cussó,Manuel Desco,Pradeep K. Garg
PLOS ONE.2018;13(10)e0205610
[DOI]
6Dual phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer
N. Yildirim-Poyraz,E. Ozdemir,B. Uzun,S. Turkolmez
Revista Espańola de Medicina Nuclear e Imagen Molecular (English Edition).2013;32(4)214
[DOI]
7PET/Computed Tomography in Renal, Bladder, and Testicular Cancer
Kirsten Bouchelouche,Peter L. Choyke
PET Clinics.2015;10(3)361
[DOI]
8The current role of PET/CT in urological malignancies
Mariana Lima,Mariana Camacho,José Barreto Campelo Carvalheira,Aline Biggi,Marcelo Lopes de Lima,Juliana Ciampi,Fernando Salis,Marina Bicalho Silveira,Ubirajara Ferreira,Elba Etchebehere
Clinical and Translational Imaging.2020;8(5)313
[DOI]
9Current Status of Hybrid PET/MRI in Oncologic Imaging
Andrew B. Rosenkrantz,Kent Friedman,Hersh Chandarana,Amy Melsaether,Linda Moy,Yu-Shin Ding,Komal Jhaveri,Luis Beltran,Rajan Jain
American Journal of Roentgenology.2016;206(1)162
[DOI]
10Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI
Andrew B. Rosenkrantz,Kent P. Friedman,Fabio Ponzo,Roy A. Raad,Kimberly Jackson,William C. Huang,Arjun V. Balar
Clinical Nuclear Medicine.2017;42(1)e8
[DOI]
11Dual phase 18F-fluorodeoxyglucose positron emission tomography/computed tomography with forced diuresis in diagnostic imaging evaluation of bladder cancer
N. Yildirim-Poyraz,E. Ozdemir,B. Uzun,S. Turkolmez
Revista Espańola de Medicina Nuclear e Imagen Molecular.2013;32(4)214
[DOI]
12Advances in bladder cancer imaging
Shaista Hafeez,Robert Huddart
BMC Medicine.2013;11(1)214
[DOI]
13Advances in bladder cancer imaging
Soichiro Yoshida,Hitoshi Masuda,Fumitaka Koga,Hiroshi Tanaka,Kazunori Kihara
BMC Medicine.2014;11(1)1173
[DOI]
14Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma
S.-C. Tsai,Y.-C. Ou,C.-L. Cheng,J.-R. Li,Y.-C. Lin,H.-C. Ho,K.-Y. Chiu,C.-K. Su,W.-Y. Lin
Nuklearmedizin.2015;54(01)36
[DOI]
15Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy
HAKAN ÖZTÜRK,INANÇ KARAPOLAT
Experimental and Therapeutic Medicine.2015;9(3)717
[DOI]
16PET in Prostate and Bladder Tumors
Sze Ting Lee,Nathan Lawrentschuk,Andrew M. Scott
Seminars in Nuclear Medicine.2012;42(4)231
[DOI]
17Detectability of residual invasive bladder cancer in delayed 18F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling
Akira Higashiyama,Tsuyoshi Komori,Hiroshi Juri,Yuki Inada,Haruhito Azuma,Yoshifumi Narumi
Annals of Nuclear Medicine.2018;32(8)561
[DOI]
18Current Role of PET, CT, MR for Invasive Bladder Cancer
Nathan Lawrentschuk,Sze Ting Lee,Andrew M. Scott
Current Urology Reports.2013;14(2)84
[DOI]
19Current Role of PET, CT, MR for Invasive Bladder Cancer
Kirsten Bouchelouche
Current Urology Reports.2016;14(2)1
[DOI]
20Renal Medullary Carcinoma on Dual-Time Point FDG PET/CT Imaging
Guozhu Hou,Yuanyuan Jiang,Jing Wang,Fang Li,Wuying Cheng
Clinical Nuclear Medicine.2020;45(6)446
[DOI]
21Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer
Lawrence O. Dierickx,Laurent Dercle,Leonor Chaltiel,Olivier Caselles,Séverine Brillouet,Slimane Zerdoud,Frédéric Courbon
The Quarterly Journal of Nuclear Medicine and Molecular Imaging.2019;63(3)446
[DOI]
22Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer
Tracy L. Rose,Yair Lotan
Urologic Oncology: Seminars and Original Investigations.2018;36(3)97
[DOI]
23Contemporary role of advanced imaging for bladder cancer staging
Soroush Rais-Bahrami,Jason A. Pietryga,Jeffrey W. Nix
Urologic Oncology: Seminars and Original Investigations.2016;34(3)124
[DOI]
2418F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer
Sarah M.H. Einerhand,Erik J. van Gennep,Laura S. Mertens,Kees Hendricksen,Maarten L. Donswijk,Henk G. van der Poel,Bas W.G. van Rhijn
Current Opinion in Urology.2020;Publish Ahead of Print(3)124
[DOI]
25Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer
Laura S. Mertens,Natascha M. Bruin,Erik Vegt,Willem M. de Blok,Annemarie Fioole-Bruining,Bas W. van Rhijn,Simon Horenblas,Wouter V. Vogel
Nuclear Medicine Communications.2012;33(11)1195
[DOI]
26Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer
Kirsten Bouchelouche,Peter L. Choyke
Nuclear Medicine Communications.2020;33(11)731
[DOI]
27PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?
Valérie Fonteyne,K. De Man,K. Decaestecker,P. De Visschere,P. Dirix,G. De Meerleer,C. Berghen,P. Ost,G. Villeirs
Clinical and Translational Imaging.2020;33(11)731
[DOI]
28PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?
Kirsten Bouchelouche
Clinical and Translational Imaging.2017;33(11)839
[DOI]
29Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography
Hakan Öztürk
Cancer Research and Treatment.2015;47(4)834
[DOI]
30Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis
Huojun Zhang,Wei Xing,Qinqin Kang,Chao Chen,Linhui Wang,Jianping Lu
Tumor Biology.2015;36(5)3209
[DOI]
31Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysis
Yu-Yu Lu,Jin-Hua Chen,Ji-An Liang,Hsin-Yi Wang,Cheng-Chieh Lin,Wan-Yu Lin,Chia-Hung Kao
European Journal of Radiology.2012;81(9)2411
[DOI]
32FDG in Urologic Malignancies
Poul Flemming Hřilund-Carlsen,Mads Hvid Poulsen,Henrik Petersen,Sřren Hess,Lars Lund
PET Clinics.2014;9(4)457
[DOI]
3311C-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial)
Antti Salminen,Ivan Jambor,Harri Merisaari,Otto Ettala,Johanna Virtanen,Ilmari Koskinen,Erik Veskimae,Jukka Sairanen,Pekka Taimen,Jukka Kemppainen,Heikki Minn,Peter J. Boström
Cancer Imaging.2018;18(1)457
[DOI]
34The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions
Ri Sa,Hong-Guang Zhao,Yu-Yin Dai,Feng Guan
Medicine.2018;97(38)e12521
[DOI]
35The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
Antoine Girard,Helena Vila Reyes,Hiram Shaish,Jean-François Grellier,Laurent Dercle,Pierre-Yves Salaün,Olivier Delcroix,Mathieu Rouanne
Frontiers in Oncology.2020;10(38)e12521
[DOI]
36Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience
R.P. Meijer,J.A. Nieuwenhuijzen,W. Meinhardt,A. Bex,H.G. van der Poel,B.W. van Rhijn,J.M. Kerst,A.M. Bergman,E. van Werkhoven,S. Horenblas
European Journal of Surgical Oncology (EJSO).2013;39(4)365
[DOI]
37Nodal disease assessment in pelvic malignancy
A K ALLOUNI,J SARKODIEH,A ROCKALL
Imaging.2013;22(1)20120016
[DOI]
38Preoperative Imaging for Staging Bladder Cancer
Maxim J. McKibben,Michael E. Woods
Current Urology Reports.2015;16(4)20120016
[DOI]
39Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer
Andrew B. Rosenkrantz,Arjun V. Balar,William C. Huang,Kimberly Jackson,Kent P. Friedman
Clinical Nuclear Medicine.2015;40(8)637
[DOI]
40Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer
Jinhai Huo,Yiyi Chu,Karim Chamie,Marc C. Smaldone,Stephen A. Boorjian,Jacques G. Baillargeon,Yong-Fang Kuo,Preston Kerr,Padraic O'Malley,Eduardo Orihuela,Douglas S. Tyler,Stephen J. Freedland,Sharon H. Giordano,Raghu Vikram,Ashish M. Kamat,Stephen B. Williams
Clinical Genitourinary Cancer.2018;16(1)e99
[DOI]
41Utilization of imaging for staging in bladder cancer
Stefano Cipollari,Giorgia Carnicelli,Marco Bicchetti,Riccardo Campa,Martina Pecoraro,Valeria Panebianco
Current Opinion in Urology.2020;30(3)377
[DOI]
42Utilization of imaging for staging in bladder cancer
Louise Dickinson,Francesco Fraioli,Athar Haroon,Clare Allen
Current Opinion in Urology.2017;30(3)59
[DOI]
43Feasible Method to enable clear visualization of suspected bladder cancer with 18F-FDG PET/CT
Na Fang,Yan-li Wang,Lei Zeng,Zeng-jie Wu,Xin-jian Cui,Qing Wang,Shan Gao,Wei Ding
Clinical Imaging.2014;38(5)704
[DOI]
  Ahead of Print  
  Call for papers  
  Search 
  Editorial Board 
  Addresses 
  Most Popular Articles 
  My Preferences 

Submit Articles

Alerts

Join us

Most popular articles